Show simple item record

The Future of Proteomics in the Study of Alcoholism

dc.contributor.authorKasinathan, Chinnaswamyen_US
dc.contributor.authorVrana, Kenten_US
dc.contributor.authorBeretta, Lauraen_US
dc.contributor.authorThomas, Paulen_US
dc.contributor.authorGooch, Randyen_US
dc.contributor.authorWorst, Travisen_US
dc.contributor.authorWalker, Stephenen_US
dc.contributor.authorXu, Aaronen_US
dc.contributor.authorPierre, Peteren_US
dc.contributor.authorGreen, Heatheren_US
dc.contributor.authorGrant, Kathleenen_US
dc.contributor.authorManowitz, Paulen_US
dc.date.accessioned2010-04-01T15:06:41Z
dc.date.available2010-04-01T15:06:41Z
dc.date.issued2004-02en_US
dc.identifier.citationKasinathan, Chinnaswamy; Vrana, Kent; Beretta, Laura; Thomas, Paul; Gooch, Randy; Worst, Travis; Walker, Stephen; Xu, Aaron; Pierre, Peter; Green, Heather; Grant, Kathleen; Manowitz, Paul (2004). "The Future of Proteomics in the Study of Alcoholism." Alcoholism: Clinical and Experimental Research 28(2): 228-232. <http://hdl.handle.net/2027.42/65576>en_US
dc.identifier.issn0145-6008en_US
dc.identifier.issn1530-0277en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/65576
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15112930&dopt=citationen_US
dc.description.abstractThis article represents the proceedings of a workshop at the 2003 annual meeting of the Research Society on Alcoholism in Fort Lauderdale, FL. The workshop organizers/chairpersons were Chinnaswamy Kasinathan and Paul Manowitz. The presentations were (1) Introduction to the field of proteomics, by Kent Vrana; (2) Use of proteomics in the identification of urinary biomarkers for alcohol intake, by Chinnaswamy Kasinathan, Paul Thomas, and Paul Manowitz; (3) Proteomics screening illuminates ethanol-mediated induction of HDL proteins in macaques, by Kent Vrana, Randy Gooch, Travis Worst, Stephen Walker, Aaron Xu, Peter Pierre, Heather Green, and Kathleen Grant; and (4) Proteomics applied to the study of the liver, by Laura Beretta.en_US
dc.format.extent66499 bytes
dc.format.extent3110 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2004 The Research Society on Alcoholismen_US
dc.subject.otherProteomicsen_US
dc.subject.otherMass Spectrometryen_US
dc.subject.otherBiomarkersen_US
dc.subject.otherHDL Proteinsen_US
dc.subject.otherHuman Proteome Organization (HUPO)en_US
dc.titleThe Future of Proteomics in the Study of Alcoholismen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherOral Biology Department, University of Medicine and Dentistry of New Jersey, Newark, New Jerseyen_US
dc.contributor.affiliationotherDepartment of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, North Carolinaen_US
dc.contributor.affiliationotherDepartment of Chemical Biology, Laboratory for Cancer Research, Rutgers, Piscataway, New Jerseyen_US
dc.contributor.affiliationotherDepartment of Psychiatry, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, New Jerseyen_US
dc.identifier.pmid15112930en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/65576/1/01.ALC.0000113779.35260.A8.pdf
dc.identifier.doi10.1097/01.ALC.0000113779.35260.A8en_US
dc.identifier.sourceAlcoholism: Clinical and Experimental Researchen_US
dc.identifier.citedreferenceAnton RF, Moak DH, Waid LR, Latham PK, Malcolm RJ, Dias JK ( 1999 ) Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial Am J Psychiatry 156 : 1758 – 1764.en_US
dc.identifier.citedreferenceChick J, Gough K, Falkowski W, Kershaw P, Hore B, Mehta B, Ritson B, Ropner R, Torley D ( 1992 ) Disulfiram treatment of alcoholism Br J Psychiatry 161 : 84 – 89.en_US
dc.identifier.citedreferenceJohnson BA, Jasinski DR, Galloway GP, Kranzler H, Weinreib R ( 1996 ) Ritanserin in the treatment of alcohol dependence—a multi-center clinical trial. Ritanserin Study Group Psychopharmacology 128 : 206 – 215.en_US
dc.identifier.citedreferenceKasinathan C, Ramaprasad P, William S, Espina N ( 1998 ) Stimulation of tyrosylprotein sulfotransferase activity by ethanol: role of increased enzyme level Alcohol 15 : 271 – 276.en_US
dc.identifier.citedreferenceLakshman R, Tsutsumi M, Ghosh P, Takase S, Anni H, Nikolaeva O ( 2001 ) Alcohol biomarkers: clinical significance and biochemical basis Alcohol Clin Exp Res 25 : 67S – 70S.en_US
dc.identifier.citedreferenceLitten RZ, Allen JP, Fertig JB ( 1995 ) Gamma-glutamyl trans-peptidase and carbohydrate deficient transferrin: alternative measures of excessive alcohol consumption Alcohol Clin Exp Res 19 : 1541 – 1546.en_US
dc.identifier.citedreferenceMcCrady BS, Langenbucher JW ( 1996 ) Alcohol treatment and health care system reform Arch Gen Psychiatry 53 : 737 – 746.en_US
dc.identifier.citedreferenceNational Directory of Drug and Alcohol Abuse Treatment Programs ( 2000 ) Substance Abuse and Mental Health Service Administration, Rockville, MD.en_US
dc.identifier.citedreferenceVolpicelli JR, Rhines KC, Rhines JS, Volpicelli LA, Alterman AI, O'Brien CP ( 1997 ) Naltrexone and alcohol dependence Arch Gen Psychiatry 54 : 737 – 742.en_US
dc.identifier.citedreferenceWeinrieb RM, O'Brien CP ( 1997 ) Naltrexone in the treatment of alcoholism Annu Rev Med 48 : 477 – 487.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.